A case of toxic epidermal necrolysis with involvement of the GI tract after systemic contrast agent application at cardiac catheterization

Garza, Austin; Waldman, Adam J.; Mamel, Jay J.

doi:10.1016/j.gie.2005.06.034

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2006

2015

Publication Types

Select...

Article5

Book1

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 10 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although dipyridamole related to severe adverse skin reaction has been reported [12], there has been no formal report of dipyridamole related to SJS. For increased use of Aggrenox in patients with ischaemic cerebrovascular disease, clinicians should be aware of the possibility of SJS occurring during use.…”

mentioning

confidence: 99%

Aggrenox (Asasantin retard)‐induced Stevens–Johnson syndrome

Jao

Tsai

Jeng

2009

Brit J Clinical Pharma

View full text Add to dashboard Cite

mentioning

confidence: 99%

Aggrenox (Asasantin retard)‐induced Stevens–Johnson syndrome

Jao

Tsai

Jeng

2009

Brit J Clinical Pharma

View full text Add to dashboard Cite

Current awareness: Pharmacoepidemiology and drug safety

2006

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 20 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Teratogens/fetal exposure; 20 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract